Calamos Advisors LLC Myovant Sciences Ltd. Transaction History

Calamos Advisors LLC

  • $16.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 12, 2021
SELL
$20.46 - $25.18 $2.57 Million - $3.16 Million
-125,649 Closed
0 $0
Q4 2020

Jan 27, 2021
BUY
$13.8 - $27.62 $318,987 - $638,436
23,115 Added 22.54%
125,649 $3.47 Million
Q3 2020

Oct 26, 2020
BUY
$14.05 - $22.6 $1.44 Million - $2.32 Million
102,534 New
102,534 $1.44 Million

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email